HEPA Hepion Pharmaceuticals, Inc.

Fundamentals / CIK 0001583771 / USD
Other share classes on CIK 0001583771: CTRVP

Hepion Pharmaceuticals, Inc. reported $5.01M in total assets and a net loss of $7.30M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open HEPA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2025), reported in USD.

$0$0$0-$45.75MFY 2017 Net Income: -$14.89M2017FY 2017 Net Income: -$13.08M2017FY 2018 Net Income: -$9.45M2018FY 2019 Net Income: -$7.04M2019FY 2020 Revenue: $0FY 2020 Net Income: -$20.35M2020FY 2021 Revenue: $0FY 2021 Net Income: -$32.72M2021FY 2022 Revenue: $0FY 2022 Net Income: -$42.20M2022FY 2023 Revenue: $0FY 2023 Net Income: -$48.93M2023FY 2024 Net Income: -$13.19M2024FY 2025 Net Income: -$8.28M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30
Revenue -- -- $0 $0 $0 $0 -- -- -- --
Research & Development $446K $11.85M $35.64M $33.27M $20.40M $12.00M $3.18M $7.59M $13.37M $13.65M
Total Operating Expenses $4.16M $19.35M $48.45M $45.49M $30.40M $20.15M $7.77M $14.59M -- $21.02M
Operating Income -$4.16M -$19.35M -$48.45M -$45.49M -$30.40M -$20.15M -$7.77M -$14.59M -$20.65M -$21.02M
EBITDA -- -$19.32M -$48.38M -$45.41M -$30.32M -$20.11M -$7.74M -$14.58M -- -$21.00M
Interest Expense -- -- $9.5K $10K $8.9K $31K $555K $339K -- --
Income Before Tax -$8.28M -$16.16M -$49.34M -$45.08M -$32.72M -$20.32M -$7.95M -$9.99M -$15.03M -$16.80M
Income Tax Expense -- -$2.97M -$409K -$2.88M $0 $31K -$909K -$536K -$1.95M -$1.91M
Net Income -$8.28M -$13.19M -$48.93M -$42.20M -$32.72M -$20.35M -$7.04M -$9.45M -$13.08M -$14.89M
Basic EPS -$0.88 -$107.35 -$616.07 -$595.00 -$940.00 -$4,200.00 -$11,900.00 -$194,700.00 -- -$285,314.69
Diluted EPS -$0.88 -$107.35 -$616.07 -$595.00 -$940.00 -$4,200.00 -$12,220.00 -$194,405.59 -- -$337,062.94
Basic Shares Outstanding 9.4M 122.9K 79.4K 76.2K 35.1K 4.8K 1.0K 92 69 52
Diluted Shares Outstanding 9.4M 122.9K 79.4K 76.2K 35.1K 4.8K 1.0K 92 69 52

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $135K $51K $70K $0 $0 $423K $22K -$592K
Total Operating Expenses $1.55M $1.21M $799K $610K $528K $1.75M $1.28M $1.20M
Operating Income -$1.55M -$1.21M -$799K -$610K -$528K -$1.75M -$1.28M -$1.20M
EBITDA -- -- -- -- -- -- -- -$1.20M
Income Before Tax -- -- -- -$657K -$473K -$1.04M -$6.11M -$1.55M
Income Tax Expense -- -- -- -- -- -- -- $0
Net Income -$4.58M -$1.25M -$811K -$657K -$473K -$1.04M -$6.11M -$1.55M
Basic EPS -$0.06 -$0.08 -$0.07 -- -$0.04 -$0.09 -$2.15 --
Diluted EPS -$0.06 -$0.08 -$0.07 -- -$0.04 -$0.09 -$2.15 --
Basic Shares Outstanding 71.1M 16.2M 11.6M -- 11.6M 11.3M 2.8M --
Diluted Shares Outstanding 71.1M 16.2M 11.6M -- 11.6M 11.3M 2.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30
Cash & Cash Equivalents $1.83M $406K $14.79M $51.19M $91.35M $40.73M $13.92M $2.83M $5.95M $12.98M
Cash & Short-Term Investments $1.83M $406K $14.79M $51.19M $91.35M $40.73M $13.92M $2.83M $5.95M $12.98M
Total Current Assets $3.07M $1.61M $17.49M $56.50M $97.45M $42.63M $14.39M $2.97M $6.06M $13.19M
Property, Plant & Equipment, Net -- -- $29K $82K $153K $108K $57K $32K $57K $68K
Goodwill -- -- -- $0 $1.87M $1.87M $1.87M $1.87M $1.87M $1.87M
Other Non-Current Assets -- -- $364K -- -- -- -- -- -- --
Total Non-Current Assets $0 $0 $607K $3.75M $6.10M $6.01M $6.22M $5.22M $5.19M $5.19M
Total Assets $3.07M $1.61M $18.09M $60.24M $103.6M $48.65M $20.61M $8.19M $11.25M $18.38M
Accounts Payable $168K $220K $2.35M $2.67M $2.45M $3.72M $492K $748K $1.56M $1.63M
Short-Term Debt -- -- -- -- -- $0 -- -- -- --
Total Current Liabilities $299K $3.14M $5.29M $7.89M $8.21M $4.66M $1.61M $2.85M $2.60M $2.94M
Total Non-Current Liabilities $103K $333K $5.52M $2.50M $2.35M $3.46M $3.39M $3.36M $4.95M $6.38M
Total Liabilities $402K $3.48M $10.81M $10.39M $10.56M $8.12M $4.99M $6.21M $7.55M $9.33M
Total Debt (incl. Leases) -- -- $209K $54K $317K $576K $807K -- -- --
Common Stock $1.2K $14 $10 $381 $7.6K $3.2K $375 $25 $979 $7.6K
Retained Earnings -$246.1M -$237.8M -$224.6M -$175.7M -$133.5M -$104.1M -$83.75M -$76.71M -$67.01M -$59.50M
Accumulated Other Comp. Income $8.3K $8.3K -$79K -$90K $0 -- -- -- -- --
Total Stockholders' Equity $2.67M -$1.86M $7.28M $49.86M $93.00M $40.52M $15.62M $1.72M $3.70M $9.06M
Total Equity $2.67M -$1.86M $7.28M $49.86M $93.00M $40.52M $15.62M $1.72M $3.70M $9.06M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $4.26M $1.63M $2.60M $1.83M $2.32M $2.92M $4.59M $406K
Cash & Short-Term Investments $4.26M $1.63M $2.60M $1.83M $2.32M $2.92M $4.59M $406K
Total Current Assets $4.94M $1.93M $2.71M $3.07M $3.74M $4.51M $6.32M $1.61M
Other Non-Current Assets $2.0K -- -- -- -- -- -- --
Total Non-Current Assets $63K $0 $0 $0 $0 $0 $0 $0
Total Assets $5.01M $1.93M $2.71M $3.07M $3.74M $4.51M $6.32M $1.61M
Accounts Payable $161K $170K $138K $168K $77K $173K $243K $220K
Short-Term Debt $300K -- -- -- -- -- -- --
Other Current Liabilities -- -- $250K -- -- -- -- --
Total Current Liabilities $1.11M $493K $736K $299K $347K $593K $936K $3.14M
Total Non-Current Liabilities $7.91M $156K $113K $103K $68K $116K $1.49M $333K
Total Liabilities $9.02M $649K $849K $402K $416K $709K $2.42M $3.48M
Total Debt (incl. Leases) $370K -- -- -- -- -- -- --
Common Stock $10K $2.9K $1.2K $1.2K $1.2K $1.2K $959 $14
Retained Earnings -$252.7M -$248.2M -$246.9M -$246.1M -$245.4M -$245.0M -$243.9M -$237.8M
Accumulated Other Comp. Income $8.3K $8.3K $8.3K $8.3K $8.3K $8.3K $8.3K $8.3K
Total Stockholders' Equity -$4.02M $1.28M $1.86M $2.67M $3.32M $3.80M $3.90M -$1.86M
Total Equity -$4.02M $1.28M $1.86M $2.67M $3.32M $3.80M $3.90M -$1.86M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30 Jun 30
Net Income -$8.28M -$13.19M -$48.93M -$42.20M -$32.72M -$20.35M -$7.04M -$9.45M -$14.89M -$17.00M
Depreciation & Amortization -- $31K $67K $77K $86K $35K $27K $19K $28K $22K
Stock-Based Compensation $21K $792K $1.34M $2.55M $4.67M $2.38M $66K $235K $1.70M $902K
Operating Cash Flow -$3.27M -$18.22M -$40.89M -$34.96M -$31.22M -$16.17M -$7.57M -$15.65M -$19.17M -$16.56M
Capital Expenditure -- -- -$14K -$16K -$130K -$88K -$51K -- -$15K -$6.6K
Free Cash Flow -- -- -$40.90M -$34.98M -$31.35M -$16.25M -$7.62M -- -$19.19M -$16.56M
Acquisitions, Net -- -- -- -- -- -- -- -- -- -$496K
Purchases of Investments -$132K -- -- -- -- -- -- -- -- --
Investing Cash Flow -$132K -$600K -$14K -$14K -$130K -$86K -$51K $900 -$15K -$502K
Common Stock Issued $9.00M $1.85M $4.49M $0 $82.15M $42.87M $7.68M $1.64M $24.66M $19.86M
Financing Cash Flow $4.83M $4.35M $4.49M -$5.14M $81.98M $43.05M $18.71M $12.52M $24.77M $19.90M
Net Change in Cash $1.42M -$14.38M -$36.40M -$40.16M $50.62M $26.80M $11.09M -$3.12M $5.58M $2.84M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$4.58M -$1.25M -$811K -$657K -$473K -$1.04M -$6.11M -$1.55M
Depreciation & Amortization -- -- -- -- -- -- -- $0
Stock-Based Compensation -- -- -- $0 $0 $0 $21K $29K
Operating Cash Flow -$882K -$1.39M $579K -$333K -$446K -$1.38M -$1.12M -$1.15M
Investing Cash Flow -- -- -- -- -- -- -- $0
Common Stock Issued -- -- -- $0 $0 $0 $9.00M $0
Financing Cash Flow $4.01M $420K $196K -$160K -$157K -$155K $5.30M $0
Net Change in Cash $2.63M -$974K $775K -$493K -$603K -$1.66M $4.18M -$1.09M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Jun 30
Return on Equity (ROE) -310.3% -- -672.0% -84.6% -35.2% -50.2% -45.1% -547.9% -353.2% -164.4%
Return on Assets (ROA) -269.6% -817.5% -270.4% -70.0% -31.6% -41.8% -34.1% -115.4% -116.2% -81.0%
Current Ratio 10.25x 0.51x 3.31x 7.16x 11.88x 9.15x 8.94x 1.04x 2.33x 4.48x
Quick Ratio 6.11x 0.13x 2.80x 6.49x 11.13x 8.74x 8.65x 0.99x 2.29x 4.41x
Debt to Equity -- -- 0.03x 0.00x 0.00x 0.01x 0.05x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -249.4% -160.6% -310.3% -275.8% -357.2% -422.1% --
Return on Assets (ROA) -145.8% -165.4% -110.2% -269.6% -245.1% -301.0% -260.3% -817.5%
Current Ratio 4.43x 3.91x 3.68x 10.25x 10.77x 7.60x 6.75x 0.51x
Quick Ratio 3.82x 3.31x 3.54x 6.11x 6.68x 4.93x 4.90x 0.13x
Source: SEC EDGAR CompanyFacts (CIK 0001583771) · from June 30, 2013 Data through September 30, 2026 · synced Nov 21, 2026, 05:13 UTC · Open in terminal